Company / Operating Cash Flow per Share
ALX ONCOLOGY HOLDINGS INC Operating Cash Flow per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.20
FY2022
5-year range
-$4.16 / -$0.36
FY2020-FY2022
Trend
-514.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -515% YoY in FY2022, a notable deviation from the 2-year average annual change of -212%.
Based on SEC 10-K filings.
-2.20 in FY2022.
Improved from $-4.16 to $-2.20 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 514.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$2.20 | -514.7% |
| FY2021 | -$0.36 | +91.4% |
| FY2020 | -$4.16 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026